BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fruit/legume fibre - Prevotella fusca |
👶
Resveratrol and its derivative pterostilbene ameliorate intestine injury in intrauterine growth-retarded weanling piglets by modulating redox status and gut microbiota. Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 12 Issue 1 Pages: 70 Pub: 2021 Jun 10 Epub: 2021 Jun 10 Authors Chen Y , Zhang H , Chen Y , Jia P , Ji S , Zhang Y , Wang T , Html Article Publication |
| fruit/legume fibre - Prevotella fusca |
👶
Review article: dietary fibre-microbiota interactions. Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther ) Vol: 42 Issue 2 Pages: 158-79 Pub: 2015 Jul Epub: 2015 May 24 Authors Simpson HL , Campbell BJ , Html Article Publication |
| fruit/legume fibre - Prevotella fusca |
👶
In vitro extraction and fermentation of polyphenols from grape seeds (Vitis vinifera) by human intestinal microbiota. Food & function (Food Funct ) Vol: 7 Issue 4 Pages: 1959-67 Pub: 2016 Apr Epub: Authors Zhou L , Wang W , Huang J , Ding Y , Pan Z , Zhao Y , Zhang R , Hu B , Zeng X , Publication Publication |
| fruit/legume fibre - Prevotella fusca |
👶
Targeted modification of gut microbiota and related metabolites via dietary fiber. Carbohydrate polymers (Carbohydr Polym ) Vol: 316 Issue Pages: 120986 Pub: 2023 Sep 15 Epub: 2023 May 16 Authors Nie Q , Sun Y , Li M , Zuo S , Chen C , Lin Q , Nie S , Publication |
| fruit/legume fibre - Prevotella fusca |
👶
Impact of tart cherries polyphenols on the human gut microbiota and phenolic metabolites in vitro and in vivo. The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 59 Issue Pages: 160-172 Pub: 2018 Sep Epub: 2018 Apr 7 Authors Mayta-Apaza AC , Pottgen E , De Bodt J , Papp N , Marasini D , Howard L , Abranko L , Van de Wiele T , Lee SO , Carbonero F , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
